Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO
· Real-Time Price · USD
7.12
-0.11 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
7.13
0.14%
After-hours: Aug 15, 2025, 06:57 PM EDT
Abeona Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.03M | -9.29M | -30.27M | 7.41M | -31.58M | -16.59M | -11.84M | -16.65M | -9.11M | -1.13M | -9.48M | -8.29M | -20.79M | -46.68M | -7.04M | -15.21M | -16M |
Depreciation & Amortization | 815K | 776K | 722K | 685K | 724K | 721K | 751K | 838K | 888K | 1.01M | 1.08M | 1.37M | 1.11M | 1.2M | 1.08M | 1.1M | 1.08M |
Stock-Based Compensation | 2.7M | 1.96M | 1.8M | 1.32M | 1.57M | 1.51M | 1.56M | 927K | 770K | 833K | 632K | 724K | 862K | 2M | 2.54M | 2.43M | 1.95M |
Other Working Capital | -1.08M | -3.8M | -126K | 327K | -1.38M | -1.15M | -1.14M | -1.55M | 684K | -639K | 1.27M | -1.27M | 231K | -16.17M | 1.08M | 2M | 2.28M |
Other Non-Cash Items | -6.47M | -6.16M | 15.69M | -24.55M | 17.57M | 4.9M | 313K | 147K | -2.28M | -10.7M | 127K | -1.25M | 6.28M | -67K | -6.75M | 141K | 125K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -793K | 1.11M | 7.61M | n/a | n/a | n/a | n/a | n/a | 32.47M | -1.76M | n/a | n/a |
Change in Working Capital | -3.42M | -3.84M | -178K | 2.45M | -2.82M | 1.01M | 2.36M | -3.15M | -2.01M | -4M | 834K | -1.57M | -1.16M | -19.17M | 1.6M | 50K | -743K |
Operating Cash Flow | -18.4M | -16.56M | -12.23M | -12.68M | -14.54M | -9.23M | -5.75M | -10.28M | -11.74M | -13.99M | -6.79M | -9.01M | -13.69M | -30.26M | -10.33M | -11.49M | -13.59M |
Capital Expenditures | -1.4M | -606K | -404K | -711K | -725K | -37K | -44K | -32K | -218K | -25K | -2K | -1.49M | -103K | -3.25M | -402K | -57K | -444K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 17K | 44K | 32K | -2.43M | 144K | 103K | 1.49M | n/a | -3.25M | 402K | n/a | 444K |
Purchase of Investments | -48.65M | -10.48M | -56.64M | -60.55M | -29.34M | -3.42M | -34.06M | -6.19M | -7.96M | -34.35M | -9.42M | -26.95M | -7.49M | -5M | -15.16M | n/a | -15.16M |
Sales Maturities Of Investments | 54.26M | 29.96M | 50.87M | 17.11M | 22.25M | 14.97M | 15.36M | 11.26M | 10.39M | 8.94M | 10.97M | 24.07M | 8.66M | 16.25M | 27.16M | 21.98M | 24.98M |
Other Investing Acitivies | n/a | n/a | n/a | 18K | n/a | n/a | -36K | 147K | 2.43M | n/a | n/a | 1.49M | n/a | 3.25M | 14.76M | n/a | -444K |
Investing Cash Flow | 4.21M | 18.88M | -6.17M | -44.13M | -7.82M | 11.53M | -18.74M | 5.21M | 2.21M | -25.29M | 1.65M | -1.4M | 1.07M | 8M | 26.76M | 21.92M | 9.38M |
Debt Repayment | n/a | -20M | n/a | n/a | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -31K | 19.8M | -299K | -14K | -977K | -319K | -4K | -5K | -4K | -5K | n/a | n/a | n/a | -1.45M | 140K | 24K | 667K |
Financial Cash Flow | 6.77M | 5.31M | -299K | 73.68M | 25.44M | 7.47M | 22.98M | 6.62M | -4K | 42.77M | 4.19M | -3.78M | n/a | 16.33M | 173K | 2.48M | 5.88M |
Net Cash Flow | -7.42M | 7.63M | -18.7M | 16.87M | 3.08M | 9.76M | -1.51M | 1.54M | -9.54M | 3.48M | -953K | -8.3M | -12.61M | -5.93M | 16.6M | 12.91M | 1.67M |
Free Cash Flow | -19.8M | -17.16M | -12.64M | -13.39M | -15.26M | -9.27M | -5.79M | -10.32M | -11.96M | -14.02M | -6.79M | -10.5M | -13.79M | -33.51M | -10.74M | -11.55M | -14.03M |